Contribution of Gastric Oxidation to Ethanol First-Pass Metabolism in Baboons:

Interactive Effect of Alcohol and Nicotine on Developing Cerebellum: An Investigation of the Temporal Pattern of Alcohol and Nicotine Administration

BACKGROUND

Among individuals who use alcohol and tobacco products, pregnant women represent a unique subpopulation that generates a greater concern because of the toxic effects of alcohol and nicotine (from cigarettes and tobacco products) on the health of both the pregnant woman and her fetus. Therefore, it is imperative to understand the interactive effects of these two substances on the fetus. Previously, we found that concurrent exposure to alcohol and nicotine did not result in the loss of greater numbers of Purkinje cells compared with each drug treatment alone, possibly as a result of a nicotine-mediated decline in peak blood alcohol concentration (BAC). The present study tested the validity of this hypothesis.

METHODS

On postnatal day (PD) 4, Sprague-Dawley rat pups were assigned to five groups, GC (no alcohol [ALC], no nicotine [NIC]), ALC (4 g/kg/day), NIC (6 mg/kg/day), ALC/NIC (ALC and NIC given concurrently), or ALC-NIC (NIC administered 6 hr after ALC exposure). These rat pups were reared in an artificial-rearing apparatus from PDs 4 to 9, and the cerebellar tissues were obtained on PD 10. The total number of cerebellar Purkinje cells in the vermis was estimated using stereological methods.

RESULTS

The results showed that alcohol significantly reduced Purkinje cell numbers. The coexposure of alcohol and nicotine did not lead to further reduction in Purkinje cell number regardless of administration method, concurrent or sequential. However, alcohol and nicotine administered concurrently but not sequentially significantly lowered the BAC.

CONCLUSION

These findings suggest that the lack of increased Purkinje cell loss after the coexposure of alcohol and nicotine is independent of nicotine's ability to lower the BAC. An alternative hypothesis might be that alcohol and nicotine target the same subpopulation of Purkinje cells; therefore, no additional Purkinje cells were lost from the coexposure of these two drugs.

Ethanol reduces cardiac myocyte function through activation of the nitric oxide-cyclic GMP pathway

We tested the hypothesis that low-dose ethanol would reduce cardiac myocyte function through increased production in the nitric oxide/cyclic GMP signal transduction pathway, rather than reduced degradation. Ventricular myocytes were isolated from the hearts of 9 rabbits. Myocyte function was studied using a video-edge detector and cyclic GMP levels were measured by radioimmunoassay. Cells were administered 5 and 10 mmol/l ethanol alone or after 10(-6) mol/l N(G)-nitro-L-arginine methyl ester (L-NAME, nitric oxide synthase inhibitor), 10(-6) mol/l 1H-[1,2,4]oxadiazolo[4,3a]quinoxalin-1-one (ODQ, soluble guanylyl cyclase inhibitor) or 10(-5) mol/l zaprinast (cyclic GMP phosphodiesterase inhibitor). Ethanol (10 mmol/l) significantly decreased percent shortening from 10.0 +/- 0.9 to 6.0 +/- 0.2%. Similar decrements occurred in the maximum rate of shortening and relaxation. After L-NAME or ODQ, the decrements in percent shortening, maximum rate of shortening and relaxation caused by ethanol were not significant. After zaprinast, ethanol significantly decreased the maximum rate of shortening and relaxation and percent shortening to 4.3 +/- 0.5. Ethanol (10 mmol/l) significantly increased cyclic GMP from 403 +/- 121 to 529 +/- 128 fmol/10(5) myocytes. Both L-NAME and ODQ lowered cyclic GMP, and ethanol did not affect cyclic GMP after either. Zaprinast raised cyclic GMP, as did its combination with 10 mmol/l ethanol (653 +/- 120). Thus, ethanol both reduced myocyte function and increased cyclic GMP. Blocking nitric oxide production or guanylyl cyclase activity prevent these effects of ethanol, while blocking cyclic GMP degradation did not. This suggests that ethanol acts as a nitric oxide stimulator in ventricular myocytes leading to reduced function and increased cyclic GMP.